ESC Premium Access

Cardiovascular risk factors during cancer treatment: prevalence, incidence and prognostic relevance.

Topic: Cardio-Oncology

Congress Presentation

About the speaker

Mr Juan Caro Codon

La Paz University Hospital, Madrid (Spain)
2 presentations
0 follower

5 more presentations in this session

Echocardiography for the 10-year prediction of cardiomyopathy in long-term survivors of childhood cancer

Speaker: Mr J. Leerink (Amsterdam, NL)


Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity

Speaker: Doctor L. Michel (Essen, DE)


Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways

Speaker: Doctor V. Quagliariello (Naples, IT)


Tamponade during immune checkpoint inhibitors therapy in lung cancer: case-reports and systematic review of the literature

Speaker: Doctor H. Mustafic (Paris, FR)


SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin 6 axis and mTORC1 /Fox01/3a mediated apoptosis

Speaker: Doctor V. Quagliariello (Naples, IT)


Access the full session


Speakers: Mr J. Caro Codon, Mr J. Leerink, Doctor L. Michel, Doctor V. Quagliariello, Doctor H. Mustafic...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb